Is the post-earnings rally in this struggling life sciences stock for real this time?

0 Min Read

RBC analyst Conor McNamara told CNBC the wait might be a little longer.

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Exit mobile version